771 related articles for article (PubMed ID: 17406658)
1. Cerebrovascular effects of hemodialysis in chronic kidney disease.
Prohovnik I; Post J; Uribarri J; Lee H; Sandu O; Langhoff E
J Cereb Blood Flow Metab; 2007 Nov; 27(11):1861-9. PubMed ID: 17406658
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging.
Jiang XL; Wen JQ; Zhang LJ; Zheng G; Li X; Zhang Z; Liu Y; Zheng LJ; Wu L; Chen HJ; Kong X; Luo S; Lu GM; Ji XM; Zhang ZJ
Metab Brain Dis; 2016 Aug; 31(4):929-36. PubMed ID: 27167984
[TBL] [Abstract][Full Text] [Related]
3. Cerebral blood flow decreases during intermittent hemodialysis in patients with acute kidney injury, but not in patients with end-stage renal disease.
Regolisti G; Maggiore U; Cademartiri C; Cabassi A; Caiazza A; Tedeschi S; Antonucci E; Fiaccadori E
Nephrol Dial Transplant; 2013 Jan; 28(1):79-85. PubMed ID: 22711517
[TBL] [Abstract][Full Text] [Related]
4. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
5. Cerebral oximetry values in dialyzed surgical patients: a comparison between hemodialysis and peritoneal dialysis.
Papadopoulos G; Dounousi E; Papathanasiou A; Papathanakos G; Tzimas P
Ren Fail; 2013 Jul; 35(6):855-9. PubMed ID: 23713678
[TBL] [Abstract][Full Text] [Related]
6. Brain hemodynamics in patients with end-stage renal disease between hemodialysis sessions.
Farhoudi M; Abedi Azar S; Abdi R
Iran J Kidney Dis; 2012 Mar; 6(2):110-3. PubMed ID: 22388608
[TBL] [Abstract][Full Text] [Related]
7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
8. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis.
Karacan O; Tutal E; Colak T; Sezer S; Eyüboğlu FO; Haberal M
Transplant Proc; 2006 Mar; 38(2):396-400. PubMed ID: 16549130
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
12. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
Cano AE; Neil AK; Kang JY; Barnabas A; Eastwood JB; Nelson SR; Hartley I; Maxwell D
Am J Gastroenterol; 2007 Sep; 102(9):1990-7. PubMed ID: 17511755
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
[TBL] [Abstract][Full Text] [Related]
15. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
[TBL] [Abstract][Full Text] [Related]
16. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
[TBL] [Abstract][Full Text] [Related]
17. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.
Kuroki Y; Tsuchida K; Go I; Aoyama M; Naganuma T; Takemoto Y; Nakatani T
Int J Mol Med; 2007 May; 19(5):783-90. PubMed ID: 17390084
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
20. Increased cerebral blood flow in anemic patients on long-term hemodialytic treatment.
Vorstrup S; Lass P; Waldemar G; Brandi L; Schmidt JF; Johnsen A; Paulson OB
J Cereb Blood Flow Metab; 1992 Sep; 12(5):745-9. PubMed ID: 1506442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
